brevicon 21-day
Pharmaranks rates Brevicon 21-Day 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Brevicon 21-Day is a combination medicine containing Ethinyl Estradiol and Norethindrone.
Ethinyl Estradiol and Norethindrone · by Allergan
Available as a generic: Norethindrone and Ethinyl Estradiol and Ferrous Fumarate
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Ethinyl Estradiol and Norethindrone
- Form
- Tablet
- Strength
- Ethinyl Estradiol 0.035MG; Norethindrone 0.5MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Allergan
- Half-life
- about 8 hours (how long it stays in your system)
- FDA application
- NDA017566
- Availability
- Discontinued (per FDA)
How long does Ethinyl Estradiol and Norethindrone stay in your body?
The elimination half-life of ethinyl estradiol and norethindrone is about 8 hours — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. This is the terminal (elimination) half-life, not a distribution phase: the label states "the mean terminal elimination half-life of norethindrone following single dose administration ... is approximately 8 hours," and its single-dose PK table gives t½ = 7.7 ± 0.5 hours (12 healthy women, 0.35 mg, fasting). Norethindrone itself is the active drug, and the label names no active metabolite that outlasts it — it is extensively reduced and then sulfate/glucuronide conjugated, with less than 5% excreted unchanged. Related point for anyone reading a different label: norethindrone ACETATE is a prodrug that is rapidly converted to norethindrone, so norethindrone is the active moiety in those products too. This label does not characterize how the half-life changes in older adults or in kidney or liver impairment — no such pharmacokinetic data is given, so no number can be quoted for those groups (the label does contraindicate use in women with significant liver disease, but that is a safety statement, not a half-life adjustment).
This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: CAMILA (norethindrone) 0.35 mg tablets — DailyMed label, Clinical Pharmacology / Pharmacokinetics.
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Brevicon 21-Day rated?
- pharmaranks gives Brevicon 21-Day a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Brevicon 21-Day?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Brevicon 21-Day. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Brevicon 21-Day?
- Brevicon 21-Day is marketed by Allergan. You can see Allergan's full profile, rating, and other products on pharmaranks.
- Is Brevicon 21-Day a brand-name or generic drug?
- Brevicon 21-Day is a brand-name product with the active ingredient Ethinyl Estradiol and Norethindrone. Lower-cost generic equivalents containing Ethinyl Estradiol and Norethindrone are available — ask your pharmacist.
- Is Brevicon 21-Day available over the counter?
- No. Brevicon 21-Day is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Brevicon 21-Day come in?
- Brevicon 21-Day is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Brevicon 21-Day FDA-registered?
- Brevicon 21-Day is on record with the U.S. FDA under application number NDA017566. You can verify this on its official FDA label.
- Has Brevicon 21-Day been recalled by the FDA?
- Brevicon 21-Day has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Brevicon 21-Day safe?
- There's no single safe-or-not verdict. pharmaranks gives Brevicon 21-Day a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Brevicon 21-Day head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
brevicon 21-day
72/100